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Abstract
Long-term depression (LTD) induced by low-frequency electrical stimulation
(LFS) in the CA1 region of the hippocampus is a form of synaptic plasticity
thought to contribute to learning and memory and to the pathophysiology of
neuropsychiatric disorders. In na€ıve hippocampal slices from juvenile rats, we
previously found that LTD induction can impair subsequent induction of
long-term potentiation (LTP) via a form of N-methyl-D-aspartate receptor
(NMDAR)-dependent metaplasticity, and have recently observed that
pharmacologically induced NMDAR-dependent LTP inhibition involves
5a-reduced neurosteroids that augment the actions of c-aminobutyric acid
(GABA). In this study, we found that both LFS-induced LTD and subsequent
inhibition of LTP induction involve neurosteroid synthesis via NMDAR
activation. Furthermore, the timing of 5a-reductase inhibition relative to LFS
can dissociate effects on LTD and metaplastic LTP inhibition. These findings
indicate that 5a-reduced neurosteroids play an important role in synaptic
plasticity and synaptic modulation in the hippocampus.
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Introduction
N-methyl-D-aspartate receptors (NMDARs) play complex
roles in synaptic function (Cull-Candy and Leszkiewicz
2004). Depending on how and when they are activated,
NMDARs in the CA1 region of the hippocampus can
induce long-term potentiation (LTP) or long-term
depression (LTD). These forms of plasticity involve the
influx of calcium through NMDAR channels and the
activation of different intracellular signaling systems. In
the case of LTP, a brief but high calcium influx results in
preferential activation of protein kinases that drive early
phases of synaptic enhancement (Malenka and Bear
2004). LTD appears to result from lower level, more

protracted increases in calcium that initially activate
protein phosphatases (Mulkey et al. 1993; Lisman 2001).
Persistent plasticity involves changes in the trafficking of
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidtype glutamate receptors, gene expression and protein
synthesis (Malenka and Bear 2004).
NMDARs can also modulate the induction of synaptic
plasticity. Certain patterns of synaptic activation (Coan
et al. 1989; Huang et al. 1992) and mildly stressful
conditions, such as brief hypoxia (Izumi et al. 1998) and
low glucose (Izumi and Zorumski 1997), can result in
NMDAR activation that results in no lasting effect on
basal synaptic transmission, but inhibits subsequent LTP
induction. These latter effects are referred to as
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“metaplasticity”, a form of synaptic modulation that alters
the ability to induce other forms of plasticity (Abraham
and Bear 1996; Abraham 2008). Although mechanisms
contributing to NMDAR-mediated LTP inhibition are less
defined than those contributing to LTP or LTD, our prior
studies indicate a role for calcium (Izumi et al. 1992),
calcineurin, and p38 mitogen-activated protein kinase
(MAPK) (Izumi et al. 2008). Recent studies also indicate
a role for NMDAR-stimulated synthesis of GABAergic
neurosteroids, including allopregnanolone (alloP), in
hippocampal pyramidal neurons (Tokuda et al. 2011).
Several of these mechanisms are shared with LTD
(Zorumski and Izumi 2012).
Prior studies also indicate that LTP induction can have
a negative impact on subsequent LTD via effects on
glycogen synthase kinase-3b (GSK3b) (Peineau et al.
2007), suggesting that the induction of both plasticity
(LTP) and metaplasticity occurs with the same stimulation paradigm. Furthermore, abbreviated patterns of stimulation used for LTD (repeated 1 Hz stimulation) can
prime synapses for LTD, making subsequent LTD induction easier (Mockett et al. 2002). It is presently unclear
how and whether induction of LTD itself influences the
mechanisms responsible for LTP and there is evidence
that LTP and LTD can overcome each other’s effects,
leading to a situation in which synapses operate over a
dynamic range of efficacy (Dudek and Bear 1992). In the
present studies, we examined whether stimulation known
to induce LTD has modulating effects on LTP induction
at Schaffer collateral synapses in rat hippocampal slices
and whether neurosteroids play a role in LTD and subsequent LTP modulation.

done at 30°C with continuous ACSF perfusion at 2 mL/
min. Extracellular recordings were obtained from the
apical dendritic layer (stratum radiatum) of the CA1
region for analysis of excitatory postsynaptic potentials
(EPSPs) using electrodes filled with 2 mol/L NaCl
(5–10 MΩ resistance).
EPSPs were evoked with 0.1 msec constant current
pulses through a bipolar stimulating electrode in the
Schaffer collateral (SC) pathway. A baseline (control)
input–output curve was obtained to determine stimulus
intensities for subsequent studies. Input–output curves
were repeated 60 min after delivery of low-frequency
stimulation (LFS; 1 Hz 9 900 pulses), and then 60 min
after delivery of high-frequency stimulation (HFS;
100 Hz 9 1 sec) using stimuli of six different intensities
to allow determination of how half maximal responses
were altered. The smallest of these six stimuli was set to
evoke a response less than half the maximum and the
strongest stimulus was set to evoke fully saturated
responses. The other four stimuli were delivered at equal
intervals between these two stimuli. On the basis of
analysis of input–output curves, we determined changes
induced by LFS and HFS. During the course of an
experiment, responses were monitored by applying single
stimuli to the SC pathway every 60 sec at half maximal
intensity. After establishing a stable control baseline for at
least 10 min, LTD was induced by applying a 1 Hz
stimulus to the SC pathway for 15 min. LTP was induced
by a single 100 Hz 9 1 sec tetanus using the same
xlintensity stimulus.

Material and Methods

Studies examining changes in neurosteroid immunofluorescence were performed independent of electrophysiological studies. Slices used for immunohistochemistry were
initially screened by electrophysiology and were incubated
with various reagents in separate 10 mL beakers as
previously described (Tokuda et al. 2010). Following LFS,
slices were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min then washed with
PBS and incubated in blocking solution (1% donkey
serum/PBS) for 2 h at 25°C. Slices were incubated with
an antibody raised in sheep against 5a-reduced neurosteroids diluted 1:2500 in 1% donkey serum/PBS for 48 h at
4°C then rinsed with PBS and incubated with secondary
antibody for 2 h at 25°C. Alexa Flour 488 donkey antisheep IgG (diluted 1:500) was used to visualize neurosteroids. Confocal images were obtained using a 609
objective (1.4 N.A.), a C1 laser scanning confocal
microscope and Z-C1 software (Nikon Instruments,
Melville, NY). All parameters were kept constant within
an experiment. Digital images were analyzed and the

Hippocampal slice preparation
Hippocampal slices were prepared from postnatal day (P)
30–32 albino rats using standard methods (Tokuda et al.
2010). Rats were anesthetized with isoflurane and decapitated. Dissected hippocampi were placed in ice-cold artificial cerebrospinal fluid (ACSF) containing (in mmol/L):
124 NaCl, 5 KCl, 2 MgSO4, 2 CaCl2, 1.25 NaH2PO4, 22
NaHCO3, 10 glucose, bubbled with 95% O2-5% CO2 at
4–6°C, and cut into 450 lm slices using a rotary slicer.
Acutely prepared slices were placed in an incubation
chamber containing gassed ACSF for at least 1 h at 30°C
before further experimentation.

Hippocampal slice physiology
At the time of study, slices were transferred individually
to a submersion-recording chamber. Experiments were

2013 | Vol. 1 | Iss. 5 | e00133
Page 2

Immunohistochemistry

ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.

Y. Izumi et al.

average intensity of the tissue was measured using
MetaMorph software (Universal Imaging Corporation,
Downingtown, PA).

Chemicals
Finasteride and Alexa Flour 488 were purchased from
Steraloids (Newport, RI) and Invitrogen (Carlsbad, CA),
respectively. All other chemicals were purchased from
Sigma (St. Louis, MO) or Tocris (St. Louis, MO). Anti-allopregnanolone antiserum was purchased from Dr. Robert
Purdy, University of California-San Diego. Drugs were
dissolved in ACSF at the time of experiment and administered by bath perfusion at the concentrations noted in the
text. The concentrations selected for study and the durations of drug administration were based on prior studies
indicating that the agents are effective at altering synaptic
transmission or synaptic plasticity when administered in
this fashion. Picrotoxin (PTXN) was dissolved in ethanol
as a 10 mmol/L stock solution. When PTXN is dissolved
in ethanol, concentrations of 0.5–1 lmol/L are sufficient
to dampen GABA-mediated inhibition while avoiding the
induction of marked epileptiform discharges.

Statistical analysis
Data were collected and analyzed using PClamp software
(Axon Instruments, Union city, CA). Data in the text are
expressed as mean  SEM 60 min following LFS or HFS,
and are normalized with respect to initial baseline recordings (taken as 100%). A two-tailed Student’s non-paired
t-test was used for comparisons between groups. In cases
of non-normally distributed data, the nonparametric Wilcoxon Rank Sum Test was used. Statistical comparisons
were based on input–output curves at baseline and
60 min following 100 Hz or 1 Hz stimulation with
P < 0.05 considered significant, and were done using
commercial software (SigmaStat; Systat Software, Inc.,
Richmond City, CA).

Results
As shown previously (Dudek and Bear 1992), low-frequency stimulation (LFS) of the SC pathway at 1 Hz for
15 min (900 pulses) results in the induction of LTD
(EPSP slope: 65.9  5.9% of baseline 1 h after LFS,
N = 6, Fig. 1A). Following stable induction of LTD for
1 h, subsequent administration of a 100 Hz 9 1 sec
high-frequency stimulus (HFS) to the same inputs failed
to induce LTP (67.3  5.7%, Fig. 1A). In na€ıve slices
from P30 rats, this form of HFS reliably induces LTP
(Izumi et al. 1992; Zorumski and Izumi 2012). After
induction of LTD, half maximal responses are reduced.

LTD, Metaplasticity and Neurosteroids

Thus, it is possible that the reduction in EPSPs alone is
responsible for the failure of LTP induction by a
subsequent HFS following LTD. In another set of experiments, we increased the intensity of the stimulus after
LTD to evoke EPSPs similar to the original baseline prior
to LTD (LTD = 66.7  4.5%, N = 5). With the enhanced
stimulus intensity, however, LTP was still not induced by
HFS (99.9  3.7% compared to the half maximal
response taken 10 min prior to HFS; Fig. 1B). These
results indicate that the failure of HFS to induce LTP
after induction of LTD is unlikely to result from using a
weak HFS. On the basis of prior results indicating a role
for NMDARs in CA1 LTD (Dudek and Bear 1992; Izumi
and Zorumski 2012) and metaplasticity (Abraham and
Bear 1996; Zorumski and Izumi 2012), we examined the
involvement of NMDARs using the broad-spectrum
NMDAR antagonist, D-2-amino-5-phosphonovalerate
(D-APV). Administration of 50 lmol/L D-APV, a concentration that totally suppresses NMDARs, before and
during LFS blocked LTD (107.5  3.2%, N = 6, Fig. 1C).
Administration of D-APV during LFS also blocked metaplastic LTP inhibition and allowed a subsequent HFS to
induce robust LTP (143.9  9.2% 1 h after HFS,
P < 0.001 vs. EPSPs 10 min before HFS, Fig. 1C). These
results indicate that the activation of NMDARs during
LFS drives LTD and also induces metaplastic LTP inhibition.
There are several subtypes of NMDARs that are
thought to contribute to synaptic plasticity (Cull-Candy
and Leszkiewicz 2004). Previous studies have reported
that the induction of LTD can be blocked by antagonists
with selectivity for NR1-/NR2B-type receptors (Liu et al.
2004; Berberich et al. 2005; Izumi et al. 2005b, 2006;
Bartlett et al. 2007), but that metaplastic LTP inhibition
is not altered by NR2B antagonists (Izumi et al. 2006).
Consistent with this, we found that 10 lmol/L ifenprodil,
an antagonist with relative selectivity for NR1/NR2B completely blocked LTD (99.7  3.5% 60 min after LFS,
N = 5), but had no effect on subsequent LTP inhibition
(99.6  5.5% of baseline 60 min after HFS, Fig. 2A).
In contrast to ifenprodil, LTP inhibition can be
prevented by low concentrations of APV (Izumi et al.
1992) that have preferential effects on NMDAR subtypes
that are not blocked by pretreatment with ifenprodil
(Izumi et al. 2006). Consistent with this, administration of
5 lmol/L D-APV just prior to and during LFS, did not
inhibit LTD induction (79.9  4.5%, N = 5) but allowed a
subsequent HFS to potentiate depressed synapses back to
original baseline levels prior to LTD (or allowed LTP
induction if compared to the level before HFS)
(102.1  24.8% of original baseline EPSPs; 156.1  38.5%
if the half maximal response 10 min before HFS is set as
100%, Fig. 2B).
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Figure 1. LFS induces LTD and LTP inhibition in the SC pathway. The graphs show the time course of change in EPSPs and traces to the right
of the graph show EPSPs at the times denoted (black traces) with initial control responses shown as red dashed lines. (A) Following LTD
induction by LFS (striped bar), HFS (arrow) failed to induce LTP. (B) As A, LFS and HFS were delivered in this order. After induction of LTD by
LFS, however, the stimulus intensity was adjusted to evoke original degrees of EPSPs. HFS was delivered at this increased intensity. In spite of
the augmented intensity, HFS failed to induce LTP. (C) In the presence of 50 lmol/L D-APV (white bar), LFS failed to induce LTD but LTP was
successfully induced by subsequent HFS (arrow) after APV washout. Dots in A show base line response without any conditioning stimulations
(N = 5). Traces to the right of the graph show EPSPs 60 min after LFS and 60 min after HFS at the times denoted with initial control responses
shown as red dashed lines. Calibration: Calibration: 1 mV, 5 msec.

We also examined the effects of 5 lmol/L APV, continuously administered throughout the experiment including
during the initial LFS and subsequent HFS, and found
that this again failed to block LTD (73.8  2.9%, N = 5)
but allowed HFS to reverse depressed synaptic responses
back to baseline (or allowed HFS to induce LTP)
(92.3  5.3%; 123.1  3.8% if the half maximal response
10 min before HFS is set as 100%, Fig. 2C). Taken
together, these results indicate that induction of
NMDAR-dependent LTD has adverse effects on LTP and
that the processes of LTD and metaplastic LTP inhibition
can be differentiated pharmacologically.
In recent studies, we found that NMDAR activation
associated with metaplastic LTP inhibition by low
concentrations of NMDA promotes the synthesis of alloP
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and other 5a-reduced neurosteroids in CA1 pyramidal
neurons and that these neurosteroids contribute to LTP
inhibition (Tokuda et al. 2011). Because alloP is a potent
positive modulator of GABA-A receptors (Akk et al.
2007), we initially examined whether PTXN, a GABA-A
receptor antagonist, alters LTD. We observed that
1 lmol/L PTXN, administered continuously throughout
an experiment, blocked the ability of LFS to induce LTD
(104.0  4.8%, N = 5; Fig. 3).
To pursue a role for neurosteroids in LFS-induced
LTD and LTP inhibition, we examined whether LFS promotes neurosteroid production in the CA1 region. Using
a previously characterized antibody against 5a-reduced
neurosteroids, including alloP (Saalman et al. 2007; Tokuda et al. 2010), we found that 1 Hz 9 900 pulse LFS
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Figure 2. NR2B-containing NMDARs contribute to LTD but not to LTP inhibition. (A) Administration of 10 lmol/L ifenprodil (black bar), an
NMDAR antagonist with selectivity for NR1-/NR2B-type receptors, completely blocks LFS (striped bar)-induced LTD but does not overcome LTP
inhibition. (B) A low concentration of D-APV (5 lmol/L, black bar), administered during LFS does not alter LTD induction by LFS but overcomes
LTP inhibition, allowing a subsequent HFS (arrow) to reverse LTD back to baseline. C. The effects of the briefer administration of 5 lmol/L APV
is mimicked by a longer APV application throughout the experiment and shows no effect on LTD, but reversal of LTP inhibition. Traces to the
right of the graph show EPSPs 60 min after LFS and 60 min after HFS at the times denoted with initial control responses shown as red dashed
lines. Calibration: 1 mV, 5 msec.

increased neurosteroid staining in CA1 pyramidal neurons
(Fluorescence Intensity: 3280  290 in control slices and
5870  540 in LFS-treated slices, N = 6 in each
condition; Fig. 4) in a fashion that was inhibited by the
NMDAR antagonist, APV (50 lmol/L) (Fluorescence
Intensity: 2870  1020). The increased staining by LFS
was also blocked by finasteride (1 lmol/L), an inhibitor
of 5a reductase, a key enzyme in neurosteroid biosynthesis (Fluorescence Intensity: 2810  480; Fig. 4).
We subsequently examined the effects of finasteride on
the ability of LFS to induce LTD and subsequent LTP inhi-

bition. When administered continuously throughout an
experiment, 1 lmol/L finasteride blocked both the induction of LTD and LTP inhibition (EPSP slope;
104.0  12.0% 1 h after LFS; 134.2  14.2% 1 h after
HFS, N = 7 Fig. 5A). In order for finasteride to affect both
LTD and LTP inhibition, the timing of administration was
critical. When administered only prior to and during LFS,
finasteride blocked LTD (97.8  2.9%, N = 5) but had no
effect on subsequent LTP inhibition induced by LFS 1 h
later (91.6  7.3%, Fig. 5B). In contrast, administration of
finasteride immediately following LFS but during subse-
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EPSPs evoked by the first pulse was 100.9  13.3% of the
control first NMDA-EPSPs, and the slope of NMDA-EPSPs
evoked by the sixth pulse was 101.3  15.9% of control
(N = 5). These findings strongly suggest that finasteride is
unlikely to depress NMDA-EPSPs even during HFS and
LFS.
Table 1 presents a summary of results from experiments under the various conditions described above in
which LFS was followed by HFS.
Figure 3. PTXN inhibits LTD induction. In the presence of 1 lmol/L
PTX (filled bar), LFS (striped bar) failed to induce LTD but
subsequent HFS could induce LTP. Traces to the right of the graph
show EPSPs at the times denoted (black traces) with initial control
responses shown as red dashed lines. Calibration: 1 mV, 5 msec.

quent HFS had no effect on LTD (56.6  4.8%, N = 5)
but allowed HFS to reverse LTD (or allowed HFS to induce
LTP if compared to levels before HFS) (101.9  13.4%;
155.8  27.5% if the half maximal response 10 min before
HFS is set as 100%, Fig. 5C). Importantly, finasteride had
no effect on NMDAR-mediated EPSPs, indicating that its
effects do not result from NMDAR antagonism (Fig. 6A,
93.4  8.1%, N = 3). Despite the lack of effect on isolated
NMDAR EPSPs, it is possible that finasteride antagonizes
NMDA-mediated responses during LFS (1 Hz) or HFS
(100 Hz). In additional studies, we tested this by measuring
the areas of NMDA-EPSPs evoked by brief trains of HFS.
NMDA-EPSPs evoked by both single and six pulses of HFS
were not altered by 30 min administration of 1 lmol/L finasteride (Fig. 6B). We also delivered six pulses of LFS
(1 Hz) to evoke NMDA-EPSPs and compared the slope of
NMDA-EPSPs. When the initial slope is normalized to
100%, the slope of EPSPs evoked by the sixth pulse was
84.3  20.2% under control conditions. Thirty minutes
after administration of 1 lmol/L finasteride, the slope of

(a)

(b)

(c)

Discussion
The present results demonstrate that LFS-induced LTD is
associated with metaplastic LTP inhibition in the SC
pathway. In young slices, we observed that HFS delivered
1 h after LFS induction failed to induce LTP. Although
previous reports show successful induction of LTP after
LFS (Wexler and Stanton 1993; Wagner and Alger 1995),
HFS was typically delivered shortly after LFS and/or in
slices from mature rats in which LFS did not induce
LTD. Both APV and finasteride block LTD and the subsequent LTP inhibition following LFS. We examined
whether LTP inhibition requires LTD and found that
both LTD and subsequent LTP inhibition require
NMDAR activation during the initial LFS. However, it
appears that LTD and subsequent LTP inhibition involves
different subtypes of NMDARs, with LTD but not LTP
inhibition being blocked by ifenprodil, a relatively selective antagonist of NR1-/NR2B-receptors (McCauley
2005). LTP, in contrast, is not sensitive to inhibitors of
specific subtypes of NMDARs (Berberich et al. 2005;
Izumi et al. 2006). Conversely, a low concentration of
APV failed to alter LTD but overcame LTP inhibition.
Although APV is a broad-spectrum NMDAR antagonist,
prior studies have suggested that APV has some limited

(d)

(e)

Figure 4. SC LFS increases neurosteroid immunoreactivity in CA1 pyramidal neurons. The photomicrographs depict immunostaining with an
antibody against 5a-reduced neurosteroids in the CA1 region in a control slice (A), a slice exposed to 1 Hz 9 15 min LFS (B), a slice exposed to
LFS in the presence of 1 lmol/L finasteride (C) and a slice exposed to LFS in the presence of 50 lmol/L D-APV (D). Panel E shows a summary of
neurosteroid immunostaining expressed in arbitrary fluorescence units. **P < 0.01 compared to controls; #P < 0.05 and ##P < 0.01 compared
to LFS. Scale bar: 50 lm.
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A

B

Figure 6. Finasteride does not alter NMDAR EPSPs. (A) In the
presence of CNQX and low magnesium administration of 1 lmol/L
finasteride (filled bar) has no effect on NMDAR EPSPs in the SC
pathway elicited by a single puse. Traces show baseline EPSPs (red
dashed top traces) with solid traces at the end of finasteride
administration. (B) NMDAR-mediated EPSP areas were measured
before and 30 min after administration of 1 lmol/L finasteride.
NMDAR-mediated EPSPs were elicited by single pulse or by trains of
six pulses at 100 Hz (open bars in histogram and solid traces are
before and red bars and red dotted traces are 30 min after
finasteride administration).

Figure 5. 5a-Reduced neurosteroids participate in LTD and LTP
inhibition. (A) Prolonged application of the 5a-reductase inhibitor,
finasteride (1 lmol/L) during both LFS and HFS prevents
homosynaptic LTD and LTP inhibition. (B) When administered for a
shorter period prior to and during LFS, 1 lmol/L finasteride (black
bar) blocks LTD induction but does not alter LTP inhibition. (C)
Administration of finasteride immediately following LFS and
continuing until delivery of HFS has no effect on LTD but allows
HFS to reverse LTD back to initial baseline levels. Traces show
representative EPSPs at the times denoted with initial control
responses shown as red dashed lines. Calibration: 1 mV, 5 msec.

preference for NR1/NR2A type NMDARs (Buller et al.
1994). We previously observed that NMDA-EPSPs
partially inhibited by ifenprodil were almost completely
suppressed by addition of 5 lmol/L APV and that
NMDA-EPSPs partially inhibited by 5 lmol/L APV were
similarly suppressed by ifenprodil, suggesting that APV, at
a low concentration, behaves like an antagonist of
NMDARs that are insensitive to ifenprodil (Izumi et al.
2006). These results indicate that LFS induces LTD via
activation of NR1-/NR2B-receptors, whereas LFS results
in metaplastic LTP inhibition via activation of other, possibly NR1/NR2A, NMDAR subtypes. These results also
indicate that metaplastic LTP inhibition associated with

Table 1. Summary of LTD-LTP studies.
Condition (N)

LFS (%)

Control (6)
50 lmol/L D-APV during LFS (6)
5 lmol/L D-APV during LFS (5)
5 lmol/L D-APV continuously (5)
1 lmol/L PTX continuously (5)
1 lmol/L Finasteride
continuously (5)
1 lmol/L Finasteride during LFS (5)
1 lmol/L Finasteride after LFS (5)

65.9
107.5
79.9
73.8
102.4
104.1








HFS (%)
5.9
3.2
4.5
2.9
2.8
12.0

97.8  2.9
56.6  4.8

67.3
143.9
102.1
92.3
166.4
134.2








5.7
9.2
24.8
5.3
18.9
14.2

91.6  7.3
101.5  13.4

1 Hz LFS does not require LTD. Although it is desirable
to use antagonists with selectivity for NR1/NR2A receptors for further investigation, our previous and preliminary studies have failed to identify reliable and highly
selective NR1/NR2A antagonists (Izumi et al. 2006).
The present results are consistent with prior studies
indicating a role for NR1-/NR2B-type NMDARs in LTD
(Liu et al. 2004; Massey et al. 2004; Berberich et al. 2005;
Bartlett et al. 2007), although this has not been observed
in all studies (Morishita et al. 2007). Previously, we found
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that NR2B-type receptors contribute to LTD in the CA1
region (Izumi et al. 2005b, 2006), but not to LTP inhibition produced by low concentrations of NMDAR agonists
or chelation of extracellular zinc (Izumi et al. 2006). Prior
studies have also shown that patterns of stimulation that
lead to LTD can have positive metaplastic effects in which
briefer trains of 1 Hz stimulation prime SC synapses for
subsequent LTD induction (Mockett et al. 2002). Furthermore, we have found that low concentrations of NMDA
(e.g., 1 lmol/L in 2 mmol/L Mg2+ 9 5 min) are sufficient to inhibit LTP but do not produce LTD (Izumi
et al. 1992), yet higher concentrations of NMDA result in
a form of “chemical” LTD (Lee et al. 1998).
On the basis of recent work showing that 5a-reduced
GABAergic neurosteroids are synthesized in CA1 pyramidal neurons (Saalman et al. 2007; Tokuda et al. 2010)
and are involved in NMDAR-mediated LTP inhibition
(Tokuda et al. 2011), we examined a possible role for
neurosteroids in LTD and LFS-mediated LTP inhibition.
These neurosteroids are synthesized from cholesterol by a
series of steps that include the trafficking of cholesterol to
mitochondria via steroid acute regulatory protein (STAR),
translocation to the inner mitochondrial membrane via
translocator protein 18 kDa (TSPO, also known as the
peripheral benzodiazepine receptor), conversion into
pregnenolone via P450 side-chain cleavage (SCC), trafficking out of mitochondria and conversion into alloP via
5a reductase and 3a-hydroxysteroid dehydrogenase
(Chisari et al. 2010; Gunn et al. 2011). In this synthetic
pathway, alloP is an end product and a potent positive
modulator of GABA-A receptors (Akk et al. 2007; Gunn
et al. 2011). Our interest in these neurosteroids was
prompted by evidence that pyramidal neurons express the
machinery for cholesterol homeostasis (Valdez et al.
2010) and are the principal cells in the CA1 region that
express STAR (King et al. 2002), TSPO (Tokuda et al.
2010), the SCC enzyme (Kimoto et al. 2001) and 5a
reductase (Agis-Balboa et al. 2006). Furthermore,
NMDAR activation (Kimoto et al. 2001), including lower
level NMDAR activation that results in LTP inhibition,
enhances neurosteroid production in CA1 pyramidal
neurons (Tokuda et al. 2011).
We found that both LTD and the metaplastic effects of
LFS are blocked by finasteride, a 5a -reductase inhibitor.
Interestingly, the timing of finasteride administration
allowed dissociation of LTD and metaplasticity. When
administered only prior to and during LFS, finasteride
inhibited LTD but did not alter LTP inhibition. In
contrast, administration of finasteride following LFS and
during HFS allowed LTD induction but prevented LTP
inhibition, whereas continuous administration throughout
the recording period prevented both processes. Again,
these findings support the idea that LTP inhibition does
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not require LTD. These findings further suggest that even
though key events occur during LFS, enhanced neurosteroid production is likely an ongoing process triggered by
NMDAR activation during the initial LFS.
How neurosteroids participate in LTD and LTP
inhibition is uncertain, although the prominent effects of
alloP on GABA-A receptors are leading possibilities (Akk
et al. 2007; Gunn et al. 2011) and are consistent with the
ability of PTXN to inhibit LTD (present study) and LTP
inhibition (Zorumski and Izumi 2012). It is important to
note, however, that prior studies suggest that neurosteroids play a necessary but not sufficient role in LTP
inhibition. That is, administration of exogenous alloP
alone is insufficient to inhibit LTP or to induce LTD at
concentrations up to 1 lmol/L (Izumi et al. 2007;
Tokuda et al. 2010). Rather, alloP appears to work in
concert with other mechanisms to dampen LTP induction. For example, in the case of the amnesic benzodiazepine, midazolam, effects on LTP and learning require
activation of both TSPO and the flumazenil-sensitive benzodiazepine site on GABA-A receptors (Tokuda et al.
2010). Neither effect alone is sufficient to inhibit LTP.
Whether neurosteroids play a similar permissive role in
LTD by interacting with other mechanisms involved in
LTD and LTP inhibition remains to be determined.
Our results have implications for the roles of LTP and
LTD in learning and memory. Both forms of plasticity
are thought to contribute to specific forms of learning
and to hippocampal network function (Martin et al.2000;
Kemp and Manahan-Vaughan 2007). Furthermore,
metaplastic LTP inhibition appears to be relevant to a
variety of stressful conditions, including brief hypoxia
(Izumi et al. 1998), low glucose (Izumi and Zorumski
1997), ammonia (Izumi et al. 2005a, 2013), and acute
behavioral stress (Kim et al. 1996; Yang et al. 2008).
Thus, this form of metaplasticity could be relevant to
learning defects observed in a range of neuropsychiatric
disorders and could provide novel approaches for
cognitive enhancement.
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